<DOC>
	<DOCNO>NCT00453778</DOCNO>
	<brief_summary>Investigate asthmatic treat FLIXOTIDE ( FP ) 500 mcg BID 14 day get reduce bronchial reactivity inhalation Leukotriene D4 . Two 14 day treatment period patient receive FP 500 MCG BID placebo . Washout least 21 day treatment . Bronchial challenge methacholine Leukotriene D4 perform start treatment period treatment day 13 14 respectively .</brief_summary>
	<brief_title>A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Inclusion : Diagnosed history asthma Non smoker last two year &lt; 5 pack year FEV1 &gt; 70 % predict Mild stable asthma Only use short act b2agonist rescue last 4 week Have history atopy . Exclusion : Any significant respiratory disease , asthma Subjects seasonal asthma may include season Use oral inhale glucocorticosteroid last 3 month longacting oral b2agonists , anticholinergic bronchodilator , cromones , antihistamine , theophylline antileukotrienes within two week Upper low RTI within 6 week Evidence disease investigator mind would affect result study Participating another study within 4 week Females pregnant , intend lactate Methacholine PD20 &gt; 454mcg Negative scin prick test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>mild asthma</keyword>
	<keyword>FLIXOTIDE</keyword>
	<keyword>methacholine</keyword>
	<keyword>bronchial challenge</keyword>
	<keyword>leukotriene D4</keyword>
</DOC>